Significant reduction in pain intensity and opioid use in two separate study groups.
Showed reduced pain and reduced opioid medication use post surgery.
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.
| Website: | www.herontx.com |
| Email: | ir@herontx.com |
| Main Phone: | +1 858 251-4400 |
| Address: | 4242 Campus Point Court |
| Address 2: | Suite 200 |
| State: | CA |
| City / Town: | San Diego |
| Country: | US |
| Postal Code: | 92121 |
| Exchange: | NSC |
| CEO: | Barry D. Quart |
| Employees: | 223 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Significant reduction in pain intensity and opioid use in two separate study groups.
Showed reduced pain and reduced opioid medication use post surgery.
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
